The Manufacturing of Complex Biologics episode artwork

EPISODE · Oct 2, 2023 · 21 MIN

The Manufacturing of Complex Biologics

from The Biotech Pulse · host Forbion

The first episode of The Biotech Pulse concentrates on the Manufacturing of Complex Bioligics. Forbion General Partner Rogier Rooswinkel speaks to Replimune CEO Philip Astley-Sparke. Philip Astley-Sparke is not only the company's Chief Executive Officer, but he is also its co-founder and has served as a member of its Board since its formation in 2015. Philip was previously the President and CEO of BioVex Inc that developed the first oncolytic therapy which was approved in the U.S. and Europe in 2015. Biovex was acquired by Amgen for up to $1bn in 2011. Tune in to listen to Philip's insight about Contract Development and Manufacturing Organizations (CDMOs) and when to recognize how and when is the right time to go it alone.See omnystudio.com/listener for privacy information.

NOW PLAYING

The Manufacturing of Complex Biologics

0:00 21:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Biotech Pulse?

This episode is 21 minutes long.

When was this The Biotech Pulse episode published?

This episode was published on October 2, 2023.

What is this episode about?

The first episode of The Biotech Pulse concentrates on the Manufacturing of Complex Bioligics. Forbion General Partner Rogier Rooswinkel speaks to Replimune CEO Philip Astley-Sparke. Philip Astley-Sparke is not only the company's Chief Executive...

Can I download this The Biotech Pulse episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!